Filing Details
- Accession Number:
- 0001751980-25-000015
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-07-03 19:54:20
- Reporting Period:
- 2025-07-01
- Filing Date:
- 2025-07-03
- Accepted Time:
- 2025-07-03 19:54:20
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1321732 | Penumbra Inc | PEN | Surgical & Medical Instruments & Apparatus (3841) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1751980 | Johanna Roberts | One Penumbra Place Alameda CA 94502 | Evp, Gen. Counsel & Secretary | No | Yes | No | No |
Transaction Summary
| Sold: | 600 shares | Avg. Price: $252.70 | Total Value: $151,621.65 |
| Number of Shares After Transactions: | 66,057 shares | ||
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2025-07-01 | 8 | $247.61 | 66,649 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2025-07-01 | 2 | $249.27 | 66,647 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2025-07-01 | 7 | $249.91 | 66,640 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2025-07-01 | 81 | $251.16 | 66,559 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2025-07-01 | 270 | $251.84 | 66,289 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2025-07-01 | 46 | $252.87 | 66,243 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2025-07-01 | 31 | $253.84 | 66,212 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2025-07-01 | 93 | $254.80 | 66,119 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2025-07-01 | 62 | $255.72 | 66,057 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- The sales were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan.
- This transaction was executed in multiple trades at prices ranging from $247.37 to $248.05. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the SEC staff, the Issuer or a security holder of the Issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.
- A portion of these shares is subject to vesting.
- This transaction was executed in multiple trades at prices ranging from $249.24 to $249.29. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the SEC staff, the Issuer or a security holder of the Issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $249.54 to $250.36. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the SEC staff, the Issuer or a security holder of the Issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $250.61 to $251.33. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the SEC staff, the Issuer or a security holder of the Issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $251.38 to $252.35. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the SEC staff, the Issuer or a security holder of the Issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $252.43 to $253.36. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the SEC staff, the Issuer or a security holder of the Issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $253.40 to $254.28. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the SEC staff, the Issuer or a security holder of the Issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $254.37 to $255.36. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the SEC staff, the Issuer or a security holder of the Issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $255.37 to $256.08. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the SEC staff, the Issuer or a security holder of the Issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.
Billionaire Hedge Funds
